Fig. 3
From: Mesenchymal stem cell-mediated delivery of therapeutic adenoviral vectors to prostate cancer
Free Adbic suppresses and chemosensitizes prostate tumors. Six treatment groups of male nude mice, each group containing seven mice, were treated differently with anti-cancer therapeutic agents. Free Adbic (3 × 107 pfu/mouse) given on days 1, 5, and 9 of treatment and cisplatin (5 mg/kg) or irinotecan (40 mg/kg) given on days 1 and 9 of treatment as indicated by the arrows (▲). All the treatment groups, that either received monotherapy or combined therapy, showed reduced tumor growth as compared to the untreated (control) group